Crossref
journal-article
Elsevier BV
European Journal of Pharmacology (78)
References
52
Referenced
85
10.1002/art.1780350315
/ Arthritis Rheum. / Nerve growth factor in the synovial fluid of patients with chronic arthritis by Aloe (1992)10.1517/13543776.8.3.301
/ Exp. Opin. Ther. Patents / Cannabinoid receptor agonists and antagonists by Barth (1998)10.1074/jbc.272.6.3315
/ J. Biol. Chem. / Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes by Bisogno (1997)10.1042/bj3220671
/ Biochem. J. / Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoyl-glycerol in mouse neuroblastoma cells by Bisogno (1997)10.1006/bbrc.1999.0254
/ Biochem. Biophys. Res. Commun. / Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function by Bisogno (1999)10.1016/S0014-2999(99)00349-0
/ Eur. J. Pharmacol. / Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor by Calandra (1999)10.1038/28393
/ Nature / Control of pain initiation by endogenous cannabinoids by Calignano (1998)10.1038/sj.bjp.0702758
/ Br. J. Pharmacol. / The cannabinoid CB1 receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal neurones in the rat by Chapman (1999){'key': '10.1016/S0014-2999(00)00226-0_BIB9', 'first-page': '586', 'article-title': 'In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity', 'volume': '277', 'author': 'Compton', 'year': '1996', 'journal-title': 'J. Pharmacol. Exp. Ther.'}
/ J. Pharmacol. Exp. Ther. / In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity by Compton (1996)10.1073/pnas.95.14.8375
/ Proc. Natl. Acad. Sci. U. S. A. / The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation by De Petrocellis (1998){'key': '10.1016/S0014-2999(00)00226-0_BIB11', 'first-page': '605', 'article-title': 'Determination and characterization of a cannabinoid receptor in rat brain', 'volume': '34', 'author': 'Devane', 'year': '1988', 'journal-title': 'Mol. Pharmacol.'}
/ Mol. Pharmacol. / Determination and characterization of a cannabinoid receptor in rat brain by Devane (1988)10.1126/science.1470919
/ Science / Isolation and structure of a brain constituent that binds to the cannabinoid receptor by Devane (1992)10.1016/S0005-2760(98)00042-3
/ Biochim. Biophys. Acta / ‘Endocannabinoids’ and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance by Di Marzo (1998)10.1016/S0014-5793(98)01175-2
/ FEBS Lett. / Interactions between synthetic vanilloids and the endogenous cannabinoid system by Di Marzo (1998)10.1016/0304-3959(77)90130-0
/ Pain / The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats by Dubuisson (1977)10.1073/pnas.92.8.3376
/ Proc. Natl. Acad. Sci. U. S. A. / Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide by Facci (1995){'key': '10.1016/S0014-2999(00)00226-0_BIB17', 'first-page': '373.2', 'article-title': 'Cannabinoids attenuate NGF-induced viscero-visceral hyper-reflexia (VVH) via CB1 and CB2 receptors', 'volume': '25', 'author': 'Farquhar-Smith', 'year': '1999', 'journal-title': 'Soc. Neurosci. Abstr.'}
/ Soc. Neurosci. Abstr. / Cannabinoids attenuate NGF-induced viscero-visceral hyper-reflexia (VVH) via CB1 and CB2 receptors by Farquhar-Smith (1999)10.1006/mcne.2000.0844
/ Mol. Cell Neurosci. / Cannabinoid CB1 receptor expression in rat spinal cord by Farquhar-Smith (2000)10.1111/j.1432-1033.1995.tb20780.x
/ Eur. J. Biochem. / Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations by Galiègue (1995)10.1073/pnas.96.25.14228
/ Proc. Natl. Acad. Sci. U. S. A. / HU-308: a specific agonist for CB2, a peripheral cannabinoid receptor by Hanus (1999)10.1523/JNEUROSCI.11-02-00563.1991
/ J. Neurosci. / Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study by Herkenham (1991)10.1016/S0304-3940(96)13308-5
/ Neurosci. Lett. / The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain by Herzberg (1997)10.1152/jn.1999.81.2.575
/ J. Neurophysiol. / Cannabinoid suppression of noxious heat-evoked activity in wide dynamic range neurons in the lumbar dorsal horn of the rat by Hohmann (1999){'key': '10.1016/S0014-2999(00)00226-0_BIB24', 'first-page': '307', 'article-title': 'Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs', 'volume': '29', 'author': 'Howlett', 'year': '1986', 'journal-title': 'Mol. Pharmacol.'}
/ Mol. Pharmacol. / Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs by Howlett (1986)10.1016/S0304-3959(98)00041-4
/ Pain / The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain by Jaggar (1998){'key': '10.1016/S0014-2999(00)00226-0_BIB26', 'first-page': '736', 'article-title': 'Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation', 'volume': '42', 'author': 'Kaminski', 'year': '1992', 'journal-title': 'Mol. Pharmacol.'}
/ Mol. Pharmacol. / Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation by Kaminski (1992)10.1016/S0014-2999(97)01160-6
/ Eur. J. Pharmacol. / SR141716A is an inverse agonist at the human cannabinoid CB1 receptor by Landsman (1997)10.1126/science.283.5400.401
/ Science / Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice by Ledent (1999){'key': '10.1016/S0014-2999(00)00226-0_BIB29', 'first-page': '422', 'article-title': 'Spinal action of cannabinoid-induced antinociception', 'volume': '105', 'author': 'Lichtman', 'year': '1991', 'journal-title': 'NIDA Res. Monogr.'}
/ NIDA Res. Monogr. / Spinal action of cannabinoid-induced antinociception by Lichtman (1991)10.1038/sj.bjp.0701915
/ Br. J. Pharmacol. / Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors by MacLennan (1998)10.1038/346561a0
/ Nature / Structure of a cannabinoid receptor and functional expression of the cloned cDNA by Matsuda (1990)10.1016/0014-2999(96)00015-5
/ Eur. J. Pharmacol. / N-(2-Hydroxyethyl)hexadecanamide is orally active in reducing oedema formation and inflammatory hyperalgesia by down-modulating mast cell activation by Mazzari (1996){'key': '10.1016/S0014-2999(00)00226-0_BIB33', 'series-title': 'Cannabinoid Receptors', 'first-page': '233', 'article-title': 'The unpaved road to the endogenous brain cannabinoid ligands, the anandamides', 'author': 'Mechoulam', 'year': '1995'}
/ Cannabinoid Receptors / The unpaved road to the endogenous brain cannabinoid ligands, the anandamides by Mechoulam (1995)10.1038/26481
/ Nature / An analgesia circuit activated by cannabinoids by Meng (1998)10.1038/365061a0
/ Nature / Molecular characterization of a peripheral receptor for cannabinoids by Munro (1993)10.1124/mol.54.6.1064
/ Mol. Pharmacol. / SR141716A acts as an inverse agonist to increase neuronal voltage-dependent Ca2+ currents by reversal of tonic CB1 cannabinoid receptor activity by Pan (1998)10.1016/S0014-2999(96)00952-1
/ Eur. J. Pharmacol. / SR141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice by Richardson (1997)10.1016/S0304-3959(97)00213-3
/ Pain / Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors by Richardson (1998)10.1016/0014-5793(94)00773-X
/ Febs Lett. / SR141716A, a potent and selective antagonist of the brain cannabinoid receptor by Rinaldi-Carmona (1994)10.1016/0024-3205(95)00174-5
/ Life Sci. / Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist by Rinaldi-Carmona (1995){'key': '10.1016/S0014-2999(00)00226-0_BIB41', 'first-page': '644', 'article-title': 'SR144528, the first potent and selective antagonist of the CB2 cannabinoid receptor', 'volume': '284', 'author': 'Rinaldi-Carmona', 'year': '1998', 'journal-title': 'J. Pharmacol. Exp. Ther.'}
/ J. Pharmacol. Exp. Ther. / SR144528, the first potent and selective antagonist of the CB2 cannabinoid receptor by Rinaldi-Carmona (1998)10.1038/sj.bjp.0703050
/ Br. J. Pharmacol. / The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1) by Smart (2000)10.1016/S0091-3057(97)00583-2
/ Pharmacol. Biochem. Behav. / Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats by Smith (1998)10.1016/S0006-8993(98)01031-2
/ Brain Res. / Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity by Strangman (1998)10.1016/S0091-3057(97)00422-X
/ Pharmacol. Biochem. Behav. / Biphasic effects of anandamide by Sulcova (1998){'key': '10.1016/S0014-2999(00)00226-0_BIB46', 'series-title': 'The Pharmacology of Pain', 'first-page': '1', 'article-title': 'Animal models of analgesia', 'author': 'Tjølsen', 'year': '1997'}
/ The Pharmacology of Pain / Animal models of analgesia by Tjølsen (1997)10.1016/0304-3959(92)90003-T
/ Pain / The formalin test: an evaluation of the method [see comments] by Tjølsen (1992)10.1016/S0896-6273(00)80564-4
/ Neuron / The cloned capsaicin receptor integrates multiple pain-producing stimuli by Tominaga (1998)10.1016/S0304-3959(96)03299-X
/ Pain / Optimal scoring strategies and weights for the formalin test in rats by Watson (1997){'key': '10.1016/S0014-2999(00)00226-0_BIB50', 'first-page': '1301', 'article-title': 'Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A', 'volume': '286', 'author': 'Welch', 'year': '1998', 'journal-title': 'J. Pharmacol. Exp. Ther.'}
/ J. Pharmacol. Exp. Ther. / Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A by Welch (1998)10.1073/pnas.96.10.5780
/ Proc. Natl. Acad. Sci. U. S. A. / Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice by Zimmer (1999)10.1038/22761
/ Nature / Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide by Zygmunt (1999)
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 25, 2002, 6:36 p.m.) |
Deposited | 5 years, 6 months ago (Feb. 4, 2020, 5:54 p.m.) |
Indexed | 4 months, 3 weeks ago (April 10, 2025, 12:58 a.m.) |
Issued | 25 years, 4 months ago (May 1, 2000) |
Published | 25 years, 4 months ago (May 1, 2000) |
Published Print | 25 years, 4 months ago (May 1, 2000) |
@article{Beaulieu_2000, title={Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat}, volume={396}, ISSN={0014-2999}, url={http://dx.doi.org/10.1016/s0014-2999(00)00226-0}, DOI={10.1016/s0014-2999(00)00226-0}, number={2–3}, journal={European Journal of Pharmacology}, publisher={Elsevier BV}, author={Beaulieu, Pierre and Bisogno, Tiziana and Punwar, Shahid and Farquhar-Smith, W.Paul and Ambrosino, Gerolmina and Di Marzo, Vincenzo and Rice, Andrew S.C}, year={2000}, month=may, pages={85–92} }